The first Royalty Pharma plc trade was made in Q4 2022.
Since then Jefferies Group bought shares two more times and sold shares on four occasions. The investor completely sold their stake between Q1 2024 and Q2 2024.
Avg closing price
Price range
Sold -137 Thousand shares
Q2 2024
Avg closing price
$27.72
Price range
$26.26
-
$29.90
Sold 18.4% shares (-30.8 Thousand shares)
Q1 2024
Avg closing price
$29.48
Price range
$27.46
-
$31.33
Increased shares by 617.2% (+144 Thousand shares)
Q4 2023
Avg closing price
$27.48
Price range
$26.21
-
$29.22
Sold 80.3% shares (-95.3 Thousand shares)
Q3 2023
Avg closing price
$29.70
Price range
$26.26
-
$31.38
Increased shares by 347.6% (+92.2 Thousand shares)
Q2 2023
Avg closing price
$33.87
Price range
$29.60
-
$36.56
Sold 17.8% shares (-5.75 Thousand shares)
Q1 2023
Avg closing price
$37.08
Price range
$32.77
-
$39.40
New holding (+32.3 Thousand shares)
Q4 2022
Avg closing price
$41.74
Price range
$39.17
-
$44.04
News about Royalty Pharma plc - Ordinary Shares - Class A and Jefferies Group